Showing results (591-600 of 1,725) with videos related to
Sort By:
Pageof 173
Drugs of Today (Barcelona, Spain : 1998)|October 17, 2009
Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single moleculeThomas M Tzschentke, Ulrich Jahnel, Babette Kogel, et al.Drugs of Today (Barcelona, Spain : 1998)|June 27, 2017
Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapiesG Escolar, M Diaz-Ricart, E Arellano-RodrigoDrugs of Today (Barcelona, Spain : 1998)|March 13, 2010
[Selective inhibitors of cyclooxygenase-2 (COX-2), celecoxib and parecoxib: a systematic review]J L MateosDrugs of Today (Barcelona, Spain : 1998)|February 6, 2010
Icatibant for hereditary angioedemaJordi GrasDrugs of Today (Barcelona, Spain : 1998)|February 6, 2010
Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar maniaFrank I Tarazi, Mohammed ShahidDrugs of Today (Barcelona, Spain : 1998)|March 5, 2010
Golimumab: A novel anti-TNF-alpha human monoclonal antibody for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitisClara Campas-MoyaDrugs of Today (Barcelona, Spain : 1998)|March 5, 2010
Eslicarbazepine acetate: A novel agent for the adjunctive treatment of epilepsyRichard T OwenDrugs of Today (Barcelona, Spain : 1998)|April 12, 2018
Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitisC N McBrien, A Menzies-GowDrugs of Today (Barcelona, Spain : 1998)|April 12, 2018
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an updateG Holleran, F Scaldaferri, G Ianiro, et al.Drugs of Today (Barcelona, Spain : 1998)|December 17, 2009
TLR2 haplotypes in the susceptibility to and severity of Chlamydia trachomatis infections in Dutch womenO Karimi, S Ouburg, H J C de Vries, et al.Pageof 173